FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Bisaccia Lisa   2. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [CVS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP and Chief HR Officer (Last) (First) (Middle) ONE CVS DRIVE 3. Date of Earliest Transaction (Month/Day/Year) 10/01/2018 (Street) WOONSOCKET, RI 02895 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 10/01/2018   M   7,764 A $ 45.07 28,850 D   Common Stock 10/01/2018   S(1)   7,764 D $ 80 21,086 D   Common Stock 10/01/2018   M   13,770 A $ 54.53 34,856 D   Common Stock 10/01/2018   S(1)   13,770 D $ 80 21,086 D   Common Stock (restricted)               17,430 D   ESOP Common Stock               592.536 I Direct Stock Unit               30,783.5442 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Stock Option

$ 45.07

10/01/2018

M

7,764

04/02/2013(2)

04/02/2019

Common Stock

7,764

$ 0

0

D

Stock Option

$ 54.53

10/01/2018

M

13,770

04/01/2014(3)

04/01/2020

Common Stock

13,770

$ 0

0

D

Phantom Stock Credits

$ 1

(4)

(4)

Common Stock

468.325

468.325

D

Stock Option

$ 74.29

04/01/2015(5)

04/01/2021

Common Stock

25,177

25,177

D

Stock Option

$ 102.26

04/01/2016(6)

04/01/2022

Common Stock

34,241

34,241

D

Stock Option

$ 104.82

04/01/2017(7)

04/01/2023

Common Stock

39,433

39,433

D

Stock Option

$ 78.05

04/03/2018(8)

04/03/2024

Common Stock

55,098

55,098

D

Stock Option

$ 62.21

04/01/2019(9)

04/01/2025

Common Stock

64,222

64,222

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Bisaccia Lisa ONE CVS DRIVE WOONSOCKET, RI 02895			EVP and Chief HR Officer

Signatures

Lisa G. Bisaccia		10/03/2018
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	All transactions were effected pursuant to a Rule 10b5-1 plan.
(2)	Option became exercisable in four equal annual installments, commencing 4/2/2013.
(3)	Option became exercisable in four equal annual installments, commencing 4/1/2014.
(4)	Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, as such time as has been elected by the reporting person.
(5)	Option became exercisable in four equal annual installments, commencing 4/1/2015.
(6)	Option became exercisable in four equal annual installments, commencing 4/1/2016.
(7)	Option became exercisable in four equal annual installments, commencing 4/1/2017.
(8)	Option became exercisable in four equal annual installments, commencing 4/3/2018.
(9)	Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.